Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma

Cholangiocarcinoma is a heterogeneous and target-rich disease with differences in actionable targets. Intrahepatic and extrahepatic types of cholangiocarcinoma differ significantly in clinical presentation and underlying genetic aberrations. Research has shown that extrahepatic cholangiocarcinoma is...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarlagadda, Bhavya, Kamatham, Vaishnavi, Ritter, Ashton, Shahjehan, Faisal, Kasi, Pashtoon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700112/
https://www.ncbi.nlm.nih.gov/pubmed/31453370
http://dx.doi.org/10.1038/s41698-019-0091-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700112/
https://www.ncbi.nlm.nih.gov/pubmed/31453370
http://dx.doi.org/10.1038/s41698-019-0091-4

Ejemplares similares